Evidence map›Paper›PMID 32534692›Full record

ArticleIndian heart journal

Expanding statin use for prevention of ASCVD in Indians: Reasoned and simplified proposals.

Enas A Enas, Basil Varkey, Rajeev Gupta

Open access · goldAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian heart journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India.Journal of clinical hypertension (Greenwich, Conn.) · 2025
    Observational
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Enas A EnasCoronary Artery Disease in Indians (CADI) Research Foundation, Lisle, IL, USA. Electronic address: cadiusa.org@gmail.com.
Basil VarkeyMedical College of Wisconsin, Milwaukee, WI, USA.
Rajeev GuptaDepartment of Preventive Cardiology & Internal Medicine, Eternal Heart Care Centre & Research Institute, Jaipur, India.
Eternal Hospital · INMedical College of Wisconsin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis, a systemic disease, is the predominant cause of cardiovascular disease (CVD) that far exceeds other causes (egs: congenital, hypertension, arrhythmia). CVD is the leading cause of mortality globally (18 million lives, including 9 million from coronary artery disease (CAD) annually).

Indexed as

AdultAtherosclerosisCoronary Artery DiseaseFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIncidenceIndiaMaleMiddle AgedPrimary PreventionRisk FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsAtherosclerotic cardiovascular disease (ASCVD)CholesterolHigh-intensity therapyIndiansModerate-intensity therapyRisk classificationRisk-enhancing factorsRisk factorsStatins

Identifiers

PMID32534692
PMCPMC7296246
OpenAlexW3015753374

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.